From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Mon, 4 May 2020 00:50:18 +0000

To: Collins, Francis (NIH/OD) [E];Mascola, John (NIH/VRC) [E];Lane, Cliff (NIH/NIAID)
[E]

Ce: Tabak, Lawrence (NIH/OD) [E];Parker, Ashley (NIH/OD) [E]

Subject: RE: [EXTERNAL] RE: OK to contact Joe Menetski to discuss opportunities for

alignment/ collaboration on ACTIV activities?

We need to find out precisely what he is talking about when he says “vaccine formats” and
“refined formats”. | really do not know what he is talking about.

eee eee
Cd

John/Cliff:
Let us discuss this at our morning meeting.

Thanks,
Tony

From: Collins, Francis (NIH/OD) [E]E >

Sent: Sunday, May 3, 2020 8:03 PM

To: Mascola, John (NIH/VRC) [E]
(}; Fauci, Anthony (NIH/NIAID) (E] [2 8) @>

Cre}
Ce: Tabak, Lawrence (NIH/OD) [EJ[ 8) >; Parker, Ashley (NIH/OD) [E]
ELT

"@yO); Lane, Cliff (NIH/NIAID) [E]

 

Subject: FW: [EXTERNAL] RE: OK to contact Joe Menetski to discuss opportunities for alignment/
collaboration on ACTIV activities?

Hi John, Cliff, and Tony,

See note below, where Mikael Dolsten indicates Pfizer is planningto—_ CY
Cj. He intends to discuss our master protocol possibility with Kathrin Jensen. |
am not quite sure what he means by “several vaccine formats”.

Does this timetable sound realistic?

Any suggestion about a response?

Francis

From: Dolsten, Mikael {Og
Sent: Sunday, May 3, 2020 6:26 PM
To: Collins, Francis (NIH/OD) (E] [SYD

 
